|
Mr. Marshall has served as our Vice President, Operations since December 2006. Prior to joining Amylin, Mr. Marshall was Vice President of Corporate Manufacturing at Amgen Inc. From 2002 to 2005, Mr. Marshall served as Vice President of Manufacturing for Recombinant Proteins at the Bioscience Division of Baxter International, where he was responsible for five facilities with a VOS of over $1.3 Billion. From 1999 to 2002, he was Site Head of the Baxter International Thousand Oaks facility, where he supported increased sales through expansion of the facility into a Quad-Suite and Formulation, Fill and Finishing operation. He joined Creative BioMolecules in 1992, first as Head of Process Development and Clinical Manufacturing and then as Head of Operations, where he managed two manufacturing sites responsible for the production and commercial supply of the OP-1 implant device. From 1988 to 1992, Mr. Marshall held various Management positions with Welgen Manufacturing Partnership (now Amgen, Rhode Island), Repligen Corporation, and Damon Biotech. He serves as a board member for Medicago, Inc., and is a member of ISPE and ASCB. Mr. Marshall received his M.S. and B.S. in Biology from the University of Massachusetts at Dartmouth, and performed three years of post-graduate work at Brown University in hematology and coagulation research. | 